The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells

Blood Cancer Discovery · Published 2026-07-21 · Available online 17 Jul 2026 · DOI 10.1158/2643-3230.bcd-25-0498

Authors (32)

Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, Tracy N. Young, Anna E. Krug, Connon I. Thomas, Caitlin Price, Monica Ransom, Regan Miller, Ana Vujovic, Mohammad Minhajuddin, Mark J. Althoff, Anthony J. Saviola, Brett M. Stevens, Robert S. Welner, Ekaterina L. Andrianova, Andrei V. Gudkov, Anza Darehshouri, Julie A. Reisz, Travis Nemkov, Angelo D'Alessandro, Austin E Gillen, Daniel A. Pollyea, Craig T. Jordan, Eric M. Pietras

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Patel, S., Moskop, D., Moreira, S., et al. (2026). The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-25-0498

Related articles